COVID-19 linked to higher dementia risk in older adults, study finds

Research indicates a potential link between COVID-19 and an increased risk of new-onset dementia in adults over 60, with the risk being similar to that from other respiratory infections.

MindBio Therapeutics Corp. Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials | Psychedelic Invest

MindBio Therapeutics Corp. reported durability data from Phase 2A clinical trials in depressed patients testing MB22001, MindBio’s proprietary self-administered take home microdose of Lysergic Acid

August 20, 2024

Psychedelic Conference in Vancouver Focuses on Spirit

During the 1960s, Vancouver had a cultural shift; Vancouver’s West End quickly became a vibrant hub that embraced rebellion against societal norms. As the Summer of

October 18, 2023

Chicago biotech Emalex says it cleared a Phase 3 for Tourette syndrome, will seek FDA approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 26, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.